MAPK3 and cancer: Several studies have reported that metformin inhibits adhesion and invasion in vitro in a variety of different cancers through multiple cell singling pathways, such as NF-kB, MMP-2/9, AKT/ERK1/2, PKC and JUK/AP-1 [70–73].